BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1375043)

  • 21. [Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
    Lira P; Grebe G
    Rev Med Chil; 1984 Oct; 112(10):1021-5. PubMed ID: 6085597
    [No Abstract]   [Full Text] [Related]  

  • 22. Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
    Carde P; Cavalli F; Diehl V; Franklin J
    Hematol J; 2000; 1(4):282-90. PubMed ID: 11920203
    [No Abstract]   [Full Text] [Related]  

  • 23. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
    Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
    Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
    Longo DL
    J Natl Cancer Inst; 2003 Jul; 95(13):928-9. PubMed ID: 12837820
    [No Abstract]   [Full Text] [Related]  

  • 25. Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
    Bonadonna G; Viviani S; Bonfante V; Gianni AM; Valagussa P
    Eur J Cancer; 2005 May; 41(7):998-1006. PubMed ID: 15862748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 27. [Controversy regarding the treatment of Hodgkin's disease].
    Balwierz W; Armata J
    Pol Tyg Lek; 1989 Apr; 44(14):315-9. PubMed ID: 2482966
    [No Abstract]   [Full Text] [Related]  

  • 28. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
    Viviani S; Santoro A; Ragni G; Bonfante V; Bestetti O; Bonadonna G
    Eur J Cancer Clin Oncol; 1985 May; 21(5):601-5. PubMed ID: 2408897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
    Longo DL
    Cancer Invest; 1996; 14(4):353-60. PubMed ID: 8689431
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fatal Bacillus cereus sepsis and rhabdomyolysis in a patient with Hodgkin's disease].
    Gómez-Herruz P; Gil-Fernández JJ; Guillen H; Arizcorreta A
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):232-3. PubMed ID: 21324561
    [No Abstract]   [Full Text] [Related]  

  • 31. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
    Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
    Ezzat HM; Cheung MC; Hicks LK; Boro J; Montaner JS; Lima VD; Harris M; Leitch HA
    Leuk Lymphoma; 2012 Dec; 53(12):2390-6. PubMed ID: 22642935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987.
    Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Najbar A; Radwańska U; Kaczmarek M; Ochocka M; Stańczak E; Sońta-Jakimczyk D
    Acta Paediatr Jpn; 1991 Dec; 33(6):703-8. PubMed ID: 1724869
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of advanced Hodgkin lymphoma].
    Kreissl S; Borchmann P
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1212-4. PubMed ID: 23720173
    [No Abstract]   [Full Text] [Related]  

  • 35. Follow-up of sperm concentration and motility in patients with lymphoma.
    Tal R; Botchan A; Hauser R; Yogev L; Paz G; Yavetz H
    Hum Reprod; 2000 Sep; 15(9):1985-8. PubMed ID: 10967000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the risk of solid tumor following Hodgkin's disease.
    Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's disease. A historical perspective.
    Avilés A; Díaz-Maqueo JC; Torras V; Ayala JR; Cortés HD
    Arch Invest Med (Mex); 1991; 22(1):27-33. PubMed ID: 1726450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
    Gobbi PG; Pieresca C; Federico M; Di Renzo N; Narni F; Iannitto E; Grignani G; Cavanna L; Avanzini P; Partesotti G
    J Clin Oncol; 1993 Apr; 11(4):712-9. PubMed ID: 7683044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment for localized Hodgkin's disease.
    Crowther D
    Hematol Oncol; 1984; 2(1):63-6. PubMed ID: 6203822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.